Author

T. Stamminger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Gilg· 1 shared A. Reichel· 1 shared B. Jahrsdoerfer· 1 shared B. Koch· 1 shared C. Conzelmann· 1 shared C. Kranz· 1 shared C. Read· 1 shared D. Michel· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Gilg

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies

M. Scherer, C. Read, G. Neusser, C. Kranz, R. Müller, F. Full, S. Woerz, A. Reichel, E.-M. Schilling, P. Walther, T. Stamminger

The paper shows that dual interferon and DNA damage signaling leads to the formation of giant PML nuclear bodies that trap viral genomes and capsids, providing a multilayered antiviral defense.

bioRxiv · Aug 24, 2021Microbiology

An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection

C. Conzelmann, A. Gilg, R. Gross, D. Schuetz, N. Preising, L. Staendker, B. Jahrsdoerfer, H. Schrezenmeier, K. M. Sparrer, T. Stamminger, S. Stenger, J. Muench, J. A. Mueller

This paper introduces an enzyme-based immunodetection assay to quantify SARS-CoV-2 infection by measuring viral spike protein expression in cell cultures.

Antiviral Research · Sep 1, 2020Peer-reviewedMicrobiology

The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation

J.-U. Vogel, S. Schmidt, D. Schmidt, F. Rothweiler, B. Koch, P. C. Baer, H. F. Rabenau, D. Michel, T. Stamminger, M. Michaelis, J. Cinatl

This paper shows eltrombopag inhibits HCMV replication via iron chelation, effective against drug-resistant strains and synergistic with ganciclovir.

bioRxiv · Nov 1, 2019Pharmacology & Toxicology